1. Home
  2. FGI vs GNPX Comparison

FGI vs GNPX Comparison

Compare FGI & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGI
  • GNPX
  • Stock Information
  • Founded
  • FGI 1987
  • GNPX 2009
  • Country
  • FGI United States
  • GNPX United States
  • Employees
  • FGI N/A
  • GNPX N/A
  • Industry
  • FGI Industrial Specialties
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGI Industrials
  • GNPX Health Care
  • Exchange
  • FGI Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • FGI 10.4M
  • GNPX 10.8M
  • IPO Year
  • FGI 2022
  • GNPX 2018
  • Fundamental
  • Price
  • FGI $5.32
  • GNPX $4.00
  • Analyst Decision
  • FGI
  • GNPX
  • Analyst Count
  • FGI 0
  • GNPX 0
  • Target Price
  • FGI N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • FGI 124.6K
  • GNPX 779.2K
  • Earning Date
  • FGI 11-14-2025
  • GNPX 11-14-2025
  • Dividend Yield
  • FGI N/A
  • GNPX N/A
  • EPS Growth
  • FGI N/A
  • GNPX N/A
  • EPS
  • FGI N/A
  • GNPX N/A
  • Revenue
  • FGI $135,654,095.00
  • GNPX N/A
  • Revenue This Year
  • FGI $5.57
  • GNPX N/A
  • Revenue Next Year
  • FGI $8.02
  • GNPX N/A
  • P/E Ratio
  • FGI N/A
  • GNPX N/A
  • Revenue Growth
  • FGI 6.66
  • GNPX N/A
  • 52 Week Low
  • FGI $2.28
  • GNPX $3.90
  • 52 Week High
  • FGI $12.62
  • GNPX $78.00
  • Technical
  • Relative Strength Index (RSI)
  • FGI 50.41
  • GNPX 48.41
  • Support Level
  • FGI $5.01
  • GNPX $7.71
  • Resistance Level
  • FGI $5.59
  • GNPX $5.00
  • Average True Range (ATR)
  • FGI 0.42
  • GNPX 0.74
  • MACD
  • FGI -0.00
  • GNPX -0.41
  • Stochastic Oscillator
  • FGI 80.00
  • GNPX 3.04

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: